Heart surgeon wins $6.4 million in legal battle with Houston's Memorial Hermann

Katherine Davis | | Cardiovascular Business | Economics

Miguel Gomez, III, MD, a former heart surgeon at Memorial Hermann hospital in Houston, won $6.4 million in a legal battle with the health system after alleging that it wrongly targeted him over his ethics, reports KHOU.com

While working at Memorial Hermann, Gomez spoke out about concerns that the health system was prioritizing business gains and profits over patient care, resulting in some resentment from his colleagues. He was given poor peer reviews, which damaged his reputation, he said in court documents.

“While we have the utmost respect for the judicial process, Memorial Hermann is disappointed with Wednesday’s verdict,” said Memorial Hermann spokesperson. “At trial, Dr. Gomez questioned the System’s quality review process, expressing concerns that he was unfairly targeted because his mortality data was misleading and made him look bad.”

To read the full story, follow the link below:

Local heart surgeon wins legal battle with Memorial Hermann Hospital

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Related Content

Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market
How private equity influences care for heart failure patients
Judge triples damages in antitrust lawsuit, ordering Johnson & Johnson MedTech to pay $442M
Private equity-backed cardiology group partners with advanced rounding tech specialists
Private equity's influence continues to rise in cardiology—what does that mean for patient care?
Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.